The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
API
NEW
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
Dividends
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
API Service
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
API
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
FRA, 3G6: GNI Group Ltd
03 Sep 2025
LAST:
14.60
CHANGE:
0.40
OPEN:
14.60
HIGH:
14.60
ASK:
0.00
VOLUME:
500
CHG(%):
2.67
PREV:
15.00
LOW:
14.60
BID:
0.00
CHART
Period:
End of Day
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
03 Sep 25
14.60
14.60
14.60
14.60
500
02 Sep 25
15.00
15.00
15.00
15.00
500
01 Sep 25
15.20
15.20
15.20
15.20
500
29 Aug 25
15.30
15.30
15.30
15.30
500
28 Aug 25
15.00
15.00
15.00
15.00
500
27 Aug 25
15.00
15.00
15.00
15.00
500
26 Aug 25
15.00
15.00
15.00
15.00
500
25 Aug 25
15.50
15.50
15.50
15.50
500
22 Aug 25
15.10
15.10
15.10
15.10
500
21 Aug 25
15.30
15.30
15.30
15.30
500
COMPANY PROFILE
Name:
GNI Group Ltd
About:
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. The company offers Etuary for the treatment of idiopathic pulmonary fibrosis. It also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, the company involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573 that is in phase II for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Sector:
Healthcare
Industry:
Biotechnology
Address:
Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023
Website:
https://www.gnipharma.com
ISIN:
JP3386370005
LEI:
5299005KSTCN0WVJMQ52
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Jan 01, 0001
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
Download
TECHNICAL INDICATORS
MA5:
15.02
MA10:
15.10
MA20:
15.76
MA50:
16.71
MA100:
17.47
MA200:
17.74
RSI14:
32.08
WPR14:
-100.00
MTM14:
-2.60
ROC14:
-0.15
ATR:
0.38
Week High:
15.30
Week Low:
14.60
Month High:
17.20
Month Low:
14.60
Year High:
26.23
Year Low:
8.72
Volatility:
47.70
RECENT SPLITS
Date
Ratio
02 Sep 2019
3-1
27 Jun 2018
1-10